Venture Fund Formation

CTI Capital in its new venture capital fund

CTI Capital
Key Contact
Chima Ubani

Partner, Emerging and High Growth Companies, Montréal

Team
Bradley Sendel

Associate, Emerging and High Growth Companies, Montréal

 

On May 10, 2021, CTI Capital announced its new venture capital fund. The new fund includes cash from the Fonds de solidarité FTQ, Caisse de dépôt et placement du Québec (CDPQ), Investissement Québec (IQ) and Teralys Capital. CTI Capital will use this fund to invest in biotherapeutics, medial technologies and healthcare IT.

CTI Capital is a Montreal-based private venture capital fund investing in high quality emerging life science companies.

Osler, Hoskin & Harcourt LLP advised CTI Capital with a team consisting of Chima Ubani, Liliana Korosi (Emerging & High Growth Companies), and Bradley Sendel (Corporate).

Value
-
Date Closed
May 10, 2021
Lead Office
Montréal
Key Contact
Chima Ubani

Partner, Emerging and High Growth Companies, Montréal

Team
Bradley Sendel

Associate, Emerging and High Growth Companies, Montréal